Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis
Philip J. Mease, Atul A. Deodhar, Désirée M F M van der Heijde, Frank Behrens, Alan Kivitz, Jeffrey Neal and 4 more
- Rank
- 13 of 971
- Percentile
- top 1.4%
- Where
- Annals of the Rheumatic Diseases, 2022
- Citations
- 221
From the 2022 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.